Financial Gravity Asset Management’s Haemonetics HAE Stock Holding History

Financial Gravity Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$115K	Buy	159 +21	+15%	+$2.54K	0.08%	267
2019 Q3	$17K	Sell	138 -194	-58%	-$24.6K	0.01%	497
2019 Q2	$40K	Buy	+332	New	+$32.7K	0.03%	360
2018 Q3	$1K	Buy	8 +1	+14%	+$104	﹤0.01%	1141
2018 Q2	$1K	Sell	7 -4	-36%	-$338	﹤0.01%	1171
2018 Q1	$1K	Buy	+11	New	+$755	﹤0.01%	1146

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Financial Gravity Asset Management's HAE Position: Q4 2019 in Review

Financial Gravity Asset Management increased its Haemonetics (HAE) stake by 15% in Q4 2019, buying an estimated $2.54K and bringing the position to 159 shares worth $115K. The position accounts for 0.08% of the portfolio, ranked #267.

Financial Gravity Asset Management first reported a position in HAE in Q1 2018 and has held it in 6 quarters since. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

Financial Gravity Asset Management held 159 shares of Haemonetics worth $115K as of Q4 2019.
Financial Gravity Asset Management bought 21 Haemonetics shares in Q4 2019, an estimated $2.54K.
Haemonetics made up 0.08% of Financial Gravity Asset Management's portfolio in Q4 2019, its #267 holding.
Financial Gravity Asset Management first reported a position in Haemonetics in Q1 2018 and has held it in 6 quarters since.
298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.